The overall goals of the Center are to: (1) Provide better access to standard laboratory analyses and facilities; (2) assist in recruitment of study patients with diabetes and suitable controls, and provide complex animal models such as primates for diabetes-related investigation; (3) foster the development and efficient use of new technologies relevant to diabetes research; (4) coordinate, stimulate and support collaborative studies between investigators interested in diabetes at the U of Washington; and (5) enhance the environment for research training of post doctoral fellows and predoctoral medical and basic science students interested in Diabetes and related metabolic and endocrine disorders. To accomplish these goals the Diabetes Endocrinology Research Center is organized around six core units: Administrative Core, Clinical Research Core, Cytohistochemistry Core, Immunoassay Core, Physiology Core and Tissue Culture Core. Through specific services provided,, these cores support the research of over 40 Affiliate investigators and 36 Associate investigators. This research covers the entire spectrum of diabetes investigation including (a) molecular, cellular and physiological regulation of metabolic hormones and the mechanism of hormone action, (b) etiology and pathogenesis of IDDM and NIDDM, (c) mechanism of hyperlipidemia and the role of lipoproteins in atherosclerosis, (d) etiology, pathogenesis, treatment and prevention of diabetic complications and (e) etiology and pathogenesis of obesity. In addition, the Center's Pilot and Feasibility and Molecular Studies Development Programs provide initial support for new investigators in the field of diabetes, new diabetes research by established investigators in other disciplines and encourages the application of molecular biology to problems in the field of diabetes. To enhance the scientific environment for diabetes research at the University of Washington, the Center's Enrichment Program provides a Seminar Series, Core Symposia, and Visiting Scientist Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-26
Application #
6476109
Study Section
Special Emphasis Panel (ZDK1-GRB-C (O1))
Program Officer
Abraham, Kristin M
Project Start
1977-06-01
Project End
2002-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
26
Fiscal Year
2002
Total Cost
$1,014,920
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Sosenko, Jay M; Geyer, Susan; Skyler, Jay S et al. (2018) The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1. Pediatr Diabetes 19:403-409
Smith, Laura B; Liu, Xiang; Johnson, Suzanne Bennett et al. (2018) Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful? Pediatr Diabetes 19:1025-1033
Kang, Inkyung; Chang, Mary Y; Wight, Thomas N et al. (2018) Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection. J Histochem Cytochem 66:241-259
Rubinow, Katya B; Houston, Barbara; Wang, Shari et al. (2018) Androgen receptor deficiency in monocytes/macrophages does not alter adiposity or glucose homeostasis in male mice. Asian J Androl 20:276-283
Espeland, Mark A; Carmichael, Owen; Hayden, Kathleen et al. (2018) Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci 73:484-491
Banks, W A; Farr, S A; Salameh, T S et al. (2018) Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance. Int J Obes (Lond) 42:391-397
Bingley, Polly J; Wherrett, Diane K; Shultz, Ann et al. (2018) Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes. Diabetes Care 41:653-661
RISE Consortium (2018) Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care 41:1696-1706
Olivo, Robert E; Davenport, Clemontina A; Diamantidis, Clarissa J et al. (2018) Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant 33:992-1001
Uusitalo, Ulla; Lee, Hye-Seung; Andrén Aronsson, Carin et al. (2018) Early Infant Diet and Islet Autoimmunity in the TEDDY Study. Diabetes Care 41:522-530

Showing the most recent 10 out of 1296 publications